Amarin Corporation plc
NASDAQ:AMRN · NASDAQ Global Market
+$0.29 today
Vol 0.09M · Avg 0.07M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+27.22%
Period High
$20.25
Period Low
$12.60
Latest
$16.03
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alto Neuroscience, Inc.
NYSE:ANRO
$782.59M
DBV Technologies S.A.
NASDAQ:DBVT
$378.32M
Silence Therapeutics plc
NASDAQ:SLN
$326.39M
Cellectis S.A.
NASDAQ:CLLS
$307.28M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$305.94M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$293.31M
AC Immune S.A.
NASDAQ:ACIU
$241.41M
Altimmune, Inc.
NASDAQ:ALT
$238.81M
Korro Bio, Inc.
NASDAQ:KRRO
$128.50M
enGene Holdings Inc.
NASDAQ:ENGN
$88.57M
What is the latest AMRN filing?
The latest filing shown is 8-K dated May 15, 2026.
How many recent filings does AMRN have?
Intrinsic Alpha currently shows 20 recent filings for AMRN.
Explore More
Continue the stock analysis
Jump to another research area for this company.